Type
1.
Al Sada H, Soofi ME, Riad H. Hansen’s disease presenting with penile nodules. European journal of dermatology : EJD. 2013;23(2):281-2.
Type
1.
Berthe S, Faye O, Bagayogo B, Dicko A, Traore P, Coulibaly K, et al. [Etiology of acquired hypochromic patches in dermatological area in Mali]. Le Mali medical. 2012;27(1):6-9.
Type
1.
Hotez P, Asojo O, Adesina A. Nigeria: “Ground Zero" for the High Prevalence Neglected Tropical Diseases. PLoS Negl Trop Dis [Internet]. 2012;6:e1600. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3409117/pdf/pntd.0001600.pdf
Type
1.
Walsh G, Cruz E, Abalos R, Tan E, Fajardo T, Villahermosa L, et al. Limited susceptibility of cynomolgus monkeys (Macaca fascicularis) to leprosy after experimental administration of Mycobacterium leprae. The American journal of tropical medicine and hygiene. 2012;87(2):327-36.
Type
1.
van Brakel WH, Sihombing B, Djarir H, Beise K, Kusumawardhani L, Yulihane R, et al. Disability in people affected by leprosy: the role of impairment, activity, social participation, stigma and discrimination. Global health action [Internet]. 2012;5. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3402069/pdf/GHA-5-18394.pdf
Type
1.
Ribeiro S, Pereira H, Mangueira CL, Ferreira C, Rosseto E, Scheinberg M. The development of arthritis and antinuclear antibodies correlate with serum 25-hydroxyvitamin D levels in patients with leprosy. Annals of the rheumatic diseases. 2012;71(12):2062-3.
Type
1.
Henriques CC, Lopéz B, Mestre T, Grima B, Panarra A, Riso N. Leprosy and rheumatoid arthritis: consequence or association? BMJ case reports. 2012;2012.
Type
1.
Bourée P, Carsalade G-Y. [Current status of leprosy]. La Revue du praticien. 2012;62(6):751-5.
Type
1.
Hacker M, Sales A, Illarramendi X, Nery J, Duppre N, Bastos F, et al. A profile of patients treated at a national leprosy outpatient referral clinic in Rio de Janeiro, Brazil, 1986-2007. Revista panamericana de salud publica = Pan American journal of public health [Internet]. 2012;31(6):485-91. Available from: http://www.scielosp.org/pdf/rpsp/v31n6/v31n6a06.pdf
Type
1.
Thai, Huong, Ba, Schurr, Truman, Alcais, et al. PARK2 Mediates Interleukin 6 and Monocyte Chemoattractant Protein 1 Production by Human Macrophages. PLoS neglected tropical diseases [Internet]. 2013;7(1):e2015. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3547867/pdf/pntd.0002015.pdf